BenLewisMD

Associate Professor of Psychiatry. Psychedelic Research. Huntsman Mental Health Institute, University of Utah.

[BenLewisMD @BenLewisMD]

"Big" TED just published my TEDx talk from last September. You can check it out here: https://t.co/bagHiB9fmx

[BenLewisMD @BenLewisMD]

@RCarhartHarris Thanks for sharing our work here! Yes, important to highlight given outsized concerns about expectancy effects and relationship to therapeutic response to psychedelics.

[BenLewisMD @BenLewisMD]

Piece in the MAPS Bulletin I wrote about some of our group psychedelic studies: https://t.co/lyUEKqUe0V @uofu_hmhi

[Matthew W. Johnson @Drug_Researcher]

Full article: https://t.co/d9MjT1Mc92

[BenLewisMD @BenLewisMD]

@NatalieRCargill Came across this today. Have read it multiple times already, each time devastated. Yes. Thanks for this.

[Natalie Cargill @NatalieRCargill]

For Margaret:
https://t.co/pev9IHrREa

[BenLewisMD @BenLewisMD]

https://t.co/iThG3sxNRi. Interview with Pamela McCall on KUER 90.1, NPR Utah on psychedelic-assisted therapies in Utah. @uofu_hmhi

[BenLewisMD @BenLewisMD]

I'm giving a presentation on our psychedelic research at the Utah Museum of Contemporary Art (UMOCA) on May 1st 6-8pm as part of their exhibition 'Altered States in the Acid West'. @uofu_hmhi @utahmoca

https://t.co/D6bLBeFD5j

[5MEO MOVIE @5MEOMOVIE]

We released this a few years ago. It was difficult to get traction from main stream media but @Graham__Hancock @michaelpollan @RCarhartHarris the late Amanda Feidling from @BeckleyResearch and @NeoPharmaco from Forbes watched and reviewed it for us. @bryan_johnson might like?

[BenLewisMD @BenLewisMD]

Our pilot was just published: Ketamine-assisted Mindfulness-Oriented Recovery Enhancement for opioid use disorder: a randomized controlled trial | Nature Mental Health. With @DrEricGarland, ⁦@uofu_hmhi⁩ https://t.co/9xyPIYVuu0

[BenLewisMD @BenLewisMD]

https://t.co/MFyp9tefcj. @uofu_hmhi @UofU_Psychiatry @UofUGiving @UofUResearch

[Psychedelics Today @PsydelicsToday]

Utah Gov. Spencer Cox signed H.B. 390 into law.

It does not legalize broad psychedelic access but it authorizes a tightly regulated clinical study at Huntsman for veterans with treatment-resistant PTSD.

A narrow step, but a meaningful one.

https://t.co/dU1SEGuFmo

[BenLewisMD @BenLewisMD]

https://t.co/MFyp9tefcj. @uofu_hmhi

[Matthew W. Johnson @Drug_Researcher]

Just published: our RCT shows psilocybin (magic mushrooms) dramatically beats nicotine patch for quitting smoking using the same psychotherapy! A single psilocybin session showed 6x greater odds of staying quit. Biologically verified. In @JAMANetworkOpen Thread 🧵 #Psychedelics #QuitSmoking

[BenLewisMD @BenLewisMD]

@Drug_Researcher @JAMANetworkOpen Amazing work! Well done. Really great to see this.

[BenLewisMD @BenLewisMD]

Utah considers legislation allowing limited use of psychedelics – Deseret News ⁦@uofu_hmhi⁩ https://t.co/UmMTNhDsyk

[Stephen Zerfas @stephen_zerfas]

Teresa of Ávila, the Desert Fathers, and Persian Sufis mapped the same meditative states the Buddhists call jhana. They never read a Buddhist text.

[BenLewisMD @BenLewisMD]

In this paper our NNDC group discusses several categories of challenges that can arise in the context of clinical trials with psychedelics including a) treatment nonresponse, b) functional unblinding / expectancy effects, c) post session difficulties, and d) contagion effects

[BenLewisMD @BenLewisMD]

https://t.co/i3c5ZE2vXY
Challenges with clinical trial participants in studies with classical psychedelics. @uofu_hmhi @FredBarrettPhD

[David B. Yaden @ExistWell]

The debate over psychological support vs psychotherapy in psychedelic treatment is confused—and that confusion matters for science, safety, and regulation.

We were confused too. So we worked it through together and published what clarified it for us... 🧵

[BenLewisMD @BenLewisMD]

Podcast discussion I had on psychedelics w “Let’s Talk About Drugs in the Intermountain West.” @uofu_hmhi https://t.co/r5iLb8KDEw